ATE224716T1 - Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid - Google Patents

Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid

Info

Publication number
ATE224716T1
ATE224716T1 AT98929515T AT98929515T ATE224716T1 AT E224716 T1 ATE224716 T1 AT E224716T1 AT 98929515 T AT98929515 T AT 98929515T AT 98929515 T AT98929515 T AT 98929515T AT E224716 T1 ATE224716 T1 AT E224716T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
cinchonine
dihydrochloride
cinchonine dihydrochloride
compositions containing
Prior art date
Application number
AT98929515T
Other languages
English (en)
Inventor
Philippe Genne
Houssam Ibrahim
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of ATE224716T1 publication Critical patent/ATE224716T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98929515T 1997-06-11 1998-06-08 Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid ATE224716T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707234A FR2764509A1 (fr) 1997-06-11 1997-06-11 Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine
PCT/FR1998/001166 WO1998056383A1 (fr) 1997-06-11 1998-06-08 Compositions pharmaceutiques contenant du dichlorhydrate de cinchonine

Publications (1)

Publication Number Publication Date
ATE224716T1 true ATE224716T1 (de) 2002-10-15

Family

ID=9507852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98929515T ATE224716T1 (de) 1997-06-11 1998-06-08 Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid

Country Status (14)

Country Link
US (1) US6528524B2 (de)
EP (1) EP0986390B1 (de)
JP (1) JP2002504109A (de)
CN (1) CN1189174C (de)
AT (1) ATE224716T1 (de)
AU (1) AU740642B2 (de)
CA (1) CA2295704A1 (de)
DE (1) DE69808287T2 (de)
DK (1) DK0986390T3 (de)
ES (1) ES2184285T3 (de)
FR (1) FR2764509A1 (de)
IL (2) IL133222A0 (de)
PT (1) PT986390E (de)
WO (1) WO1998056383A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301956B2 (en) * 2014-02-12 2016-04-05 Adam Mickiewicz University Application of cinchona alkaloid derivatives as cytotoxic compounds
US11066421B1 (en) 2021-02-09 2021-07-20 Ares Pharmaceuticals, LLC Synthetic cinchona alkaloids against cancer
US11649232B2 (en) 2021-05-10 2023-05-16 Ares Pharmaceuticals, LLC Synthetic dimeric cinchona alkaloids against cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981003564A1 (en) 1980-05-27 1981-12-10 C Rose Drum pitch modulation
DE69215999T2 (de) * 1991-02-25 1997-07-03 Debiopharm Sa Therapeutische Mittel für die Behandlungder Resistenz gegen Arzneimittel bei Krebs
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant

Also Published As

Publication number Publication date
AU7924498A (en) 1998-12-30
CN1189174C (zh) 2005-02-16
DE69808287D1 (de) 2002-10-31
FR2764509A1 (fr) 1998-12-18
US6528524B2 (en) 2003-03-04
JP2002504109A (ja) 2002-02-05
ES2184285T3 (es) 2003-04-01
DE69808287T2 (de) 2003-06-26
AU740642B2 (en) 2001-11-08
PT986390E (pt) 2003-01-31
CN1259869A (zh) 2000-07-12
DK0986390T3 (da) 2003-01-27
WO1998056383A1 (fr) 1998-12-17
IL133222A (en) 2006-08-01
EP0986390A1 (de) 2000-03-22
EP0986390B1 (de) 2002-09-25
CA2295704A1 (fr) 1998-12-17
US20020091136A1 (en) 2002-07-11
IL133222A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
FR2677984B1 (fr) Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
SE8804629D0 (sv) New therapeutically active compounds
FI872864A (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
DE69427704T2 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DE69129331D1 (de) Verwendung von inosittriphosphat zur zubereitung von medikamenten
SE8404065D0 (sv) Novel biologically active compounds
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
DE69808287D1 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
FI923751A (fi) Hexahydrobenso/f/kinolinoner
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
DE60029946D1 (de) Arzneimittel gegen glomerulosclerose
HU9802896D0 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
FR2567755B1 (fr) Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0986390

Country of ref document: EP

REN Ceased due to non-payment of the annual fee